ZIVO Bioscience, Inc. ZIVOW NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

24/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

ZIVO Bioscience, Inc. (ZIVOW) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 23/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

24/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

0/100

→ Income

✗

健康

33/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

21/100

→ Income

成长

58/100

→ Income

✗

收入

10/100

→ Income

估值概览 — ZIVOW

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.95

EV/EBITDA0.0

每股数据

EPS (TTM)$-3.92

每股账面价值$0.00

每股营收$0.05

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2015	$-21.22	$0.00	$-5.79M	-
2016	$-21.73	$0.00	$-6.06M	-
2017	$-34.60	$0.00	$-10.04M	-
2018	$-44.84	$0.00	$-14.64M	-
2019	$-25.47	$0.00	$-14.67M	-
2020	$-11.41	$20K	$-9.66M	-48278.9%
2021	$-7.39	$0.00	$-9.4M	-
2022	$-5.57	$0.00	$-8.75M	-
2023	$-4.60	$27.65K	$-7.78M	-28127.2%
2024	$-3.92	$157.22K	$-13.38M	-8513.4%